We are live on ! Find out more
CRSP icon

CRISPR Therapeutics
CRSP

Name Holding Trade Value Shares
Change 		Change in
Stake
GT
301
Glenmede Trust
Pennsylvania
$272K – – –
CLOS
302
Compagnie Lombard Odier SCmA
Switzerland
$268K +$12.6K +100 +4%
SCA
303
Spearhead Capital Advisors
Florida
$249K -$10.6K -84 -4%
QT
304
Quantamental Technologies
New York
$249K +$279K +2,221 New
KFS
305
Kurt F. Somerville
$248K – – –
WAP
306
Wealthcare Advisory Partners
Pennsylvania
$246K +$25.1K +200 +10%
PCM
307
Prelude Capital Management
New York
$237K +$251 +2 +0.1%
TI
308
Tidal Investments
Wisconsin
$233K -$162K -1,291 -38%
TFS
309
Thoroughbred Financial Services
Tennessee
$231K -$24.6K -196 -9%
MIG
310
McGuire Investment Group
Rhode Island
$229K – – –
CF
311
Centaurus Financial
California
$229K +$25.1K +200 +11%
MC
312
Moors & Cabot
Massachusetts
$228K +$18.8K +150 +8%
HC
313
Henshaw Capital
Massachusetts
$226K +$98K +780 +63%
PFO
314
Pathstone Family Office
New Jersey
$226K +$45.7K +364 +22%
QAM
315
QCI Asset Management
New York
$226K +$62.8K +500 +33%
AO
316
Advisor OS
Illinois
$225K – – –
CG
317
Colony Group
Massachusetts
$224K – – –
DMK
318
David M. Knott
$224K – – –
HCM
319
Hodges Capital Management
Texas
$224K – – –
SC
320
Scholtz & Company
Connecticut
$222K -$101K -805 -29%
CC
321
Centiva Capital
New York
$222K +$250K +1,987 New
VWA
322
V Wealth Advisors
Kansas
$221K – – –
CW
323
CreativeOne Wealth
Kansas
$220K – – –
MFG
324
Menard Financial Group
Texas
$211K +$35K +279 +17%
TCA
325
Transcend Capital Advisors
New Jersey
$211K +$279K +2,222 New
11 12
13
14 15